Patency of Femoral Tunneled Hemodialysis Catheters and Factors Predictive of Patency Failure

被引:19
|
作者
Burton, Kirsteen R. [1 ]
Guo, Lancia L. Q. [2 ]
Tan, Kong T. [1 ]
Simons, Martin E. [1 ]
Sniderman, Kenneth W. [1 ]
Kachura, John R. [1 ]
Beecroft, John R. [1 ]
Rajan, Dheeraj K. [1 ]
机构
[1] Univ Toronto, Dept Med Imaging, Div Vasc & Intervent Radiol, Univ Hlth Network, Toronto, ON, Canada
[2] Univ Calgary, Dept Radiol, Calgary, AB, Canada
关键词
Hemodialysis catheter; Hemodialysis; Central veins; Patency; Infection; Femoral vein; EXPERIENCE; INSERTION; RISK; VEIN;
D O I
10.1007/s00270-011-0316-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine the patency rates of and factors associated with increased risk of patency failure in patients with femoral vein tunneled hemodialysis catheters. All femoral tunneled catheter insertions from 1996 to 2006 were reviewed, during which time 123 catheters were inserted. Of these, 66 were exchanges. Patients with femoral catheter failure versus those with femoral catheter patency were compared. Confounding factors, such as demographic and procedural factors, were incorporated and assessed using univariate and multivariable Cox proportional hazards regression analyses. Mean catheter primary patency failure time was 96.3 days (SE 17.9 days). Primary patency at 30, 60, 90, and 180 days was 53.8%, 45.4%, 32.1%, and 27.1% respectively. Crude rates of risk of catheter failure did not suggest a benefit for patients receiving catheters introduced from one side versus the other, but more cephalad location of catheter tip was associated with improved patency. Multivariate analysis showed that patients whose catheters were on the left side (p = 0.009), were of increasing age at the time of insertion (p = 0.002) and that those who had diabetes (p = 0.001) were at significantly greater risk of catheter failure. The catheter infection rate was 1.4/1000 catheter days. Patients who were of a more advanced age and had diabetes were at greater risk of femoral catheter failure, whereas those who received femoral catheters from the right side were less at risk of catheter failure.
引用
收藏
页码:1396 / 1402
页数:7
相关论文
共 50 条
  • [21] Efficacy of tissue plasminogen activator administration on patency of hemodialysis access catheters
    Daeihagh, P
    Jordan, J
    Chen, J
    Rocco, M
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (01) : 75 - 79
  • [22] Tissue plasminogen activator use in maintaining patency in hemodialysis access catheters
    Walton, T
    Eyrich, H
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (02) : 453 - 454
  • [23] Efficacy of urokinase in maintaining patency of hemodialysis catheters: A meta-analysis
    Deng, Jiaxiu
    Luo, Weixiang
    Zhang, Weiwei
    Xiong, Shiyi
    Wang, Liping
    CLINICAL NEPHROLOGY, 2024, 102 (04) : 212 - 222
  • [24] Conversion of temporary hemodialysis catheters to tunneled hemodialysis catheters
    Falk, A
    Parthasarathy, S
    CLINICAL NEPHROLOGY, 2005, 63 (03) : 209 - 214
  • [25] ANTIMICROBIAL AGENTS AND CHEMOTHERAPY FOR BACTEREMIA ASSOCIATED WITH TUNNELED FEMORAL CATHETERS FOR HEMODIALYSIS
    Gerasimovska, V.
    Oncevski, A.
    Gerasimovska-Kitanovska, B.
    Sikole, A.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2010, 33 (07): : 463 - 463
  • [26] Factors affecting the patency and complications of peripheral intravenous catheters in newborns
    Tseng, Ju-Huei
    Chen, Ying-Fang Elaine
    Chang, Sun-Peng
    Wang, Hsiao-Chin
    Kuo, Yung-Ting
    PEDIATRICS AND NEONATOLOGY, 2023, 64 (04): : 239 - 246
  • [27] Factors Associated with Patency Following Angioplasty of Hemodialysis Fistulae
    Neuen, Brendon L.
    Gunnarsson, Ronny
    Baer, Richard A.
    Tosenovsky, Patrik
    Green, Stella J.
    Golledge, Jonathan
    Mantha, Murty L.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2014, 25 (09) : 1419 - 1426
  • [28] FACTORS AFFECTING THE PRIMARY PATENCY OF THE ARTERIOVENOUS FISTULAE FOR HEMODIALYSIS
    Lammouchi, M. A.
    Kheder, R.
    Jbali, H.
    Smaoui, W.
    Krid, M.
    Ben Fatma, L.
    Rais, L.
    Beji, S.
    Zouaghi, M. K.
    Ben Moussa, F.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [29] Tissue plasminogen activator use in maintaining patency in hemodialysis access catheters - Reply
    Daeihagh, P
    Rocco, MV
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (02) : 454 - 454
  • [30] Conversion of Non-Tunneled to Tunneled Hemodialysis Catheters
    Thuong G. Van Ha
    Derek Fimmen
    Laura Han
    Brian S. Funaki
    Scott Santeler
    Jonathan Lorenz
    CardioVascular and Interventional Radiology, 2007, 30 : 222 - 225